Trials / Sponsors / Australia New Zealand Gynaecological Oncology Group
Australia New Zealand Gynaecological Oncology Group
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Tislelizumab in Combination With Sitravatinib for Recurrent/Metastatic Cervical Cancer After Platinum-Based Ch Metastatic Cervical Cancer | Phase 2 | 2023-06-01 |
| Recruiting | EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma Ovarian Carcinosarcoma, Uterine Carcinosarcoma | Phase 2 | 2023-05-22 |
| Withdrawn | Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1 Ovarian Cancer, Carcinosarcoma | Phase 2 | 2019-07-29 |